Friday, October 01, 2021 3:28:00 AM
Over the last 5 years, NWBO has paid Advent about $30M (not counting the spend for Sawston).
Exw, where did you get this number? The payments to Advent have been clearly reported every year because they report all payments to related parties. I looked back to 2017 I saw a total of $25M but that includes some millions paid related to Sawston, don't know if we can be sure of exactly how many millions.
I'd really like to know what backing data you cite because I just don't see it. I think NWBO was paying a lot largely because they had to equipment effectively reserved because they needed to be prepared for trial patients and as they do now, they needed to ensure that not having guaranteed production available they would obviously have trouble getting approved on that basis and might be shunned by investors even if the trial results are really good. They ended up not needing all they had reserved. I know they settle with Cognate for some rebates but I don't remember getting any rollback from advent.
Exw, where did you get this number? The payments to Advent have been clearly reported every year because they report all payments to related parties. I looked back to 2017 I saw a total of $25M but that includes some millions paid related to Sawston, don't know if we can be sure of exactly how many millions.
I'd really like to know what backing data you cite because I just don't see it. I think NWBO was paying a lot largely because they had to equipment effectively reserved because they needed to be prepared for trial patients and as they do now, they needed to ensure that not having guaranteed production available they would obviously have trouble getting approved on that basis and might be shunned by investors even if the trial results are really good. They ended up not needing all they had reserved. I know they settle with Cognate for some rebates but I don't remember getting any rollback from advent.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
